Vera Therapeutics stock’s post-IPO rally rolls on (Nasdaq:VERA)

Biotech Vera Therapeutics (Nasdaq:VERA) popped more than 30% intraday Wednesday as the stock rallied for a fourth straight session following last week’s below-range IPO pricing.